Clinical trial
Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00005856 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00005856 |
|---|---|
| Title | Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
| Official title | Phase I/II Trial of Oxaliplatin as Neoadjuvant Treatment in Adults With Newly Diagnosed Glioblastoma Multiforme |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma |
| Intervention type | Drug, Other |
| Interventions | oxaliplatin, pharmacological study |
| Enrollment | 59 |
| Start date | Dec 1, 2000 |
| Primary completion | Jan 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: